Increased bilirubin production, ceruloplasmin concentrations and hyperbilirubinaemia in full-term newborn infants

Area of Science:

• Biochemistry
• Neonatal Medicine
• Pediatrics

Background:

• Ceruloplasmin exhibits in vitro antioxidant activity, but in vivo protective roles, especially in neonatal hyperbilirubinaemia, remain unproven.
• Oxidative haemolysis is a potential factor in neonatal hyperbilirubinaemia, with protective factors like ceruloplasmin being investigated.

Purpose of the Study:

• To investigate the in vivo role of ceruloplasmin and alphafetoprotein in protecting against oxidative haemolysis in full-term neonates.
• To determine the association between ceruloplasmin, alphafetoprotein, and carboxyhaemoglobin levels with maximum bilirubin levels in the first four days of life.

Main Methods:

• Measured cord blood ceruloplasmin and alphafetoprotein concentrations in 78 full-term neonates without G6PD deficiency or hemolytic disease.
• Assessed carboxyhaemoglobin levels on day four as an index of bilirubin production.
• Utilized multiple regression analysis to study relationships between variables and maximum bilirubin levels.

Main Results:

• Low ceruloplasmin concentrations and high carboxyhaemoglobin levels were significantly associated with higher maximum bilirubin levels (P < 0.001).
• Alphafetoprotein levels did not show a significant association with hyperbilirubinaemia.
• No correlation was found between carboxyhaemoglobin and ceruloplasmin levels.

Conclusions:

• Ceruloplasmin does not appear to play a significant protective role against oxidative haemolysis in full-term newborn infants.
• Cord blood ceruloplasmin levels are likely influenced by hepatic metabolism and are better predictors of neonatal hyperbilirubinaemia than alphafetoprotein.
• Findings suggest ceruloplasmin's antioxidant function in vivo during the neonatal period may be limited.